Call For More Transparency In Clinical Trials

Tuesday, January 29, 2013 - 18:40 in Health & Medicine

Pharmaceuticals are in decline as an industry due to over-regulation, lawsuits and cultural distrust. A new initiative from the European Medicines Agency, to commit to releasing all of the information from clinical trials once the marketing authorization process has ended, is being cheered by proponents of access to data but the pharmaceutical industry is less pleased.  Writing in an editorial, PLoS Medicine writes, "As 2013 begins, it is clear that critical times lie ahead for the publishing of clinical trials, which may define the relationship between pharmaceutical companies and the public for many years to come. read more

Read the whole article on

More from

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net